At a glance
- Originator Menarini
- Class Antiasthmatics
- Mechanism of Action Leukotriene D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 10 Jul 1998 Discontinued-Preclinical for Asthma in Spain (Unknown route)
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Asthma in Spain (Unknown route)